Nicole Erin Kinsey White

Array ( [id] => 6440444 [patent_doc_number] => 20100279416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'METHOD FOR INTRODUCING CHANGES INTO A EUKARYOTIC GENOME IN VIVO AND A KIT' [patent_app_type] => utility [patent_app_number] => 12/593558 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6438 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20100279416.pdf [firstpage_image] =>[orig_patent_app_number] => 12593558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580856 [patent_doc_number] => 20090176202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'Methods of Detecting Inhibitors of VIF-Mediated APOBEC3G Degradation and HIV' [patent_app_type] => utility [patent_app_number] => 12/054272 [patent_app_country] => US [patent_app_date] => 2008-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 8378 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176202.pdf [firstpage_image] =>[orig_patent_app_number] => 12054272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5580908 [patent_doc_number] => 20090176254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'MAMMALIAN GALANIN RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/046142 [patent_app_country] => US [patent_app_date] => 2008-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10978 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176254.pdf [firstpage_image] =>[orig_patent_app_number] => 12046142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718645 [patent_doc_number] => 20080241167 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/044845 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20657 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241167.pdf [firstpage_image] =>[orig_patent_app_number] => 12044845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886434 [patent_doc_number] => 20080260766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Epitopes, combined epitopes, use of epitopes or their combination, composition, uses of the composition, anti-HIV-1 prophylactic vaccines, therapeutic vaccines, method for the identification of epitopes and methods for treatment and prevention' [patent_app_type] => utility [patent_app_number] => 12/073401 [patent_app_country] => US [patent_app_date] => 2008-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6124 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260766.pdf [firstpage_image] =>[orig_patent_app_number] => 12073401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538737 [patent_doc_number] => 20090220542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'VACCINE COMPRISED SPECIFICALLY OF PROTEIN SUBUNITS OF HUMAN IMMUNODEFICIENCY VIRUS\'S GLYCOPROTEIN 120 PROBE TO PREVENT AND TREAT AN INFECTION CAUSED BY THE HUMAN IMMUNODEFICIENCY VIRUS' [patent_app_type] => utility [patent_app_number] => 12/040898 [patent_app_country] => US [patent_app_date] => 2008-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 6502 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220542.pdf [firstpage_image] =>[orig_patent_app_number] => 12040898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10529122 [patent_doc_number] => 09255251 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Purified bacteriophage, its preparation and application' [patent_app_type] => utility [patent_app_number] => 12/449418 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4825 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12449418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480187 [patent_doc_number] => 20090203144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'HIV-GAG CODON-OPTIMISED DNA VACCINES' [patent_app_type] => utility [patent_app_number] => 12/015756 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 14780 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203144.pdf [firstpage_image] =>[orig_patent_app_number] => 12015756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452682 [patent_doc_number] => 20090068719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'IMMUNOASSAYS, HAPTENS, IMMUNOGENS AND ANTIBODIES FOR ANTI-HIV THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/972874 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 36438 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068719.pdf [firstpage_image] =>[orig_patent_app_number] => 11972874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 288920 [patent_doc_number] => 07547533 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays' [patent_app_type] => utility [patent_app_number] => 11/968806 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5704 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547533.pdf [firstpage_image] =>[orig_patent_app_number] => 11968806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845497 [patent_doc_number] => 20080181905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Nanoemulsion Vaccines' [patent_app_type] => utility [patent_app_number] => 11/966763 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 38399 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20080181905.pdf [firstpage_image] =>[orig_patent_app_number] => 11966763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663159 [patent_doc_number] => 20080254066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Nanoemulsion Vaccines' [patent_app_type] => utility [patent_app_number] => 11/966770 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 38366 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254066.pdf [firstpage_image] =>[orig_patent_app_number] => 11966770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546006 [patent_doc_number] => 20090155883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Scientifically Modulated And Reprogrammed Treatment (SMART) Virus Technology Intended to Neutralize the Human Immunodeficiency Virus' [patent_app_type] => utility [patent_app_number] => 11/957437 [patent_app_country] => US [patent_app_date] => 2007-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3949 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155883.pdf [firstpage_image] =>[orig_patent_app_number] => 11957437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545340 [patent_doc_number] => 20090155217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Novel E. coli O157:H7 Bacteriophage and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/955176 [patent_app_country] => US [patent_app_date] => 2007-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8635 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155217.pdf [firstpage_image] =>[orig_patent_app_number] => 11955176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879283 [patent_doc_number] => 20080152666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'APOPTOSIS-INDUCING POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/949125 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6561 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20080152666.pdf [firstpage_image] =>[orig_patent_app_number] => 11949125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955386 [patent_doc_number] => 20080188410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'APOPTOSIS-INDUCING POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 11/947935 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6558 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188410.pdf [firstpage_image] =>[orig_patent_app_number] => 11947935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 330621 [patent_doc_number] => 07511117 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Compositions and methods for treating HIV infection with cupredoxin and cytochrome c' [patent_app_type] => utility [patent_app_number] => 11/943034 [patent_app_country] => US [patent_app_date] => 2007-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18925 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/511/07511117.pdf [firstpage_image] =>[orig_patent_app_number] => 11943034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839394 [patent_doc_number] => 20080279879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'INDUCTION OF BROADLY REACTIVE NEUTRALIZING ANTIBODIES BY FOCUSING THE IMMUNE RESPONSE ON V3 EPITOPES OF THE HIV-1 gp120 ENVELOPE' [patent_app_type] => utility [patent_app_number] => 11/942634 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20172 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279879.pdf [firstpage_image] =>[orig_patent_app_number] => 11942634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4825032 [patent_doc_number] => 20080124359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease' [patent_app_type] => utility [patent_app_number] => 11/985696 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8299 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124359.pdf [firstpage_image] =>[orig_patent_app_number] => 11985696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 337766 [patent_doc_number] => 07504107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-17 [patent_title] => 'Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response' [patent_app_type] => utility [patent_app_number] => 11/935188 [patent_app_country] => US [patent_app_date] => 2007-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6792 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/504/07504107.pdf [firstpage_image] =>[orig_patent_app_number] => 11935188 [rel_patent_id] =>[rel_patent_doc_number] =>)